Larry Schlesinger - Publications

Affiliations: 
Integrated Biomedical Sciences Ohio State University, Columbus, Columbus, OH 
Area:
Molecular Biology, Microbiology Biology

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Arnett E, Wolff J, Leopold Wager CM, Simper J, Badrak JL, Ontiveros CO, Ni B, Schlesinger LS. Cutting Edge: Cytosolic Receptor AIM2 Is Induced by Peroxisome Proliferator-activated Receptor γ following Mycobacterium tuberculosis Infection of Human Macrophages but Does Not Contribute to IL-1β Release. Journal of Immunology (Baltimore, Md. : 1950). PMID 38251918 DOI: 10.4049/jimmunol.2300418  0.329
2024 Olmo-Fontánez AM, Scordo JM, Schami A, Garcia-Vilanova A, Pino PA, Hicks A, Mishra R, Jose Maselli D, Peters JI, Restrepo BI, Nargan K, Naidoo T, Clemens DL, Steyn AJC, Thacker VV, ... ... Schlesinger LS, et al. Human alveolar lining fluid from the elderly promotes Mycobacterium tuberculosis intracellular growth and translocation into the cytosol of alveolar epithelial cells. Mucosal Immunology. PMID 38185331 DOI: 10.1016/j.mucimm.2024.01.001  0.38
2023 Arnett E, Pahari S, Leopold Wager CM, Hernandez E, Bonifacio JR, Lumbreras M, Renshaw C, Montoya MJ, Opferman JT, Schlesinger LS. Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 168: 115738. PMID 37864894 DOI: 10.1016/j.biopha.2023.115738  0.303
2023 Sadee W, Cheeseman IH, Papp A, Pietrzak M, Seweryn M, Zhou X, Lin S, Williams AM, Wewers MD, Curry HM, Zhang H, Cai H, Kunsevi-Kilola C, Tshivhula H, Walzl G, ... ... Schlesinger LS, et al. Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability. Research Square. PMID 37333188 DOI: 10.21203/rs.3.rs-2986649/v1  0.334
2023 Leopold Wager CM, Bonifacio JR, Simper J, Naoun AA, Arnett E, Schlesinger LS. Activation of transcription factor CREB in human macrophages by Mycobacterium tuberculosis promotes bacterial survival, reduces NF-kB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling. Plos Pathogens. 19: e1011297. PMID 37000865 DOI: 10.1371/journal.ppat.1011297  0.395
2022 Simper JD, Perez E, Schlesinger LS, Azad AK. Resistance and Susceptibility Immune Factors at Play during Infection of Macrophages. Pathogens (Basel, Switzerland). 11. PMID 36297211 DOI: 10.3390/pathogens11101153  0.358
2022 Jurkowitz MS, Azad AK, Monsma PC, Keiser TL, Kanyo J, Lam TT, Bell CE, Schlesinger LS. Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids. The Journal of Biological Chemistry. 101849. PMID 35314194 DOI: 10.1016/j.jbc.2022.101849  0.745
2022 Singh DK, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger LS, Artyomov MN, Khader SA, Kaushal D. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Nature Communications. 13: 679. PMID 35115549 DOI: 10.1038/s41467-022-28315-7  0.34
2022 Allué-Guardia A, Garcia-Vilanova A, Olmo-Fontánez AM, Peters J, Maselli DJ, Wang Y, Turner J, Schlesinger LS, Torrelles JB. Host- and Age-Dependent Transcriptional Changes in Cell Envelope Biosynthesis Genes after Exposure to Human Alveolar Lining Fluid. International Journal of Molecular Sciences. 23. PMID 35055170 DOI: 10.3390/ijms23020983  0.313
2021 Singh B, Singh DK, Ganatra SR, Escobedo RA, Khader S, Schlesinger LS, Kaushal D, Mehra S. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas. Mbio. e0318921. PMID 34903057 DOI: 10.1128/mbio.03189-21  0.309
2021 Allué-Guardia A, Garcia-Vilanova A, M Olmo-Fontánez A, Peters J, Maselli DJ, Wang Y, Turner J, Schlesinger LS, Torrelles JB. Host- and age-dependent transcriptional changes in cell envelope biosynthesis genes after exposure to human alveolar lining fluid. Biorxiv : the Preprint Server For Biology. PMID 34580670 DOI: 10.1101/2021.09.08.459334  0.311
2021 Singh D, Aladyeva E, Das S, Singh B, Esaulova E, Swain A, Ahmed M, Cole J, Moodley C, Mehra S, Schlesinger L, Artyomov M, Khader S, Kaushal D. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Research Square. PMID 34282414 DOI: 10.21203/rs.3.rs-664507/v1  0.315
2021 Piergallini TJ, Scordo JM, Pino PA, Schlesinger LS, Torrelles JB, Turner J. Acute Inflammation Confers Enhanced Protection against Mycobacterium tuberculosis Infection in Mice. Microbiology Spectrum. e0001621. PMID 34232086 DOI: 10.1128/Spectrum.00016-21  0.358
2020 Bartlett S, Gemiarto AT, Ngo MD, Sajiir H, Hailu S, Sinha R, Foo CX, Kleynhans L, Tshivhula H, Webber T, Bielefeldt-Ohmann H, West NP, Hiemstra AM, MacDonald CE, Christensen LVV, ... Schlesinger LS, et al. GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Infection and Is Associated With TB Disease Severity. Frontiers in Immunology. 11: 601534. PMID 33240287 DOI: 10.3389/fimmu.2020.601534  0.328
2020 Crouser ED, Locke LW, Julian MW, Bicer S, Sadee W, White P, Schlesinger LS. Phagosome-regulated mTOR Signalling during Sarcoidosis Granuloma Biogenesis. The European Respiratory Journal. PMID 32943400 DOI: 10.1183/13993003.02695-2020  0.315
2020 Sivangala Thandi R, Radhakrishnan RK, Tripathi D, Paidipally P, Azad AK, Schlesinger LS, Samten B, Mulik S, Vankayalapati R. Ornithine-A urea cycle metabolite enhances autophagy and controls Mycobacterium tuberculosis infection. Nature Communications. 11: 3535. PMID 32669568 DOI: 10.1038/s41467-020-17310-5  0.323
2019 Pahari S, Negi S, Aqdas M, Arnett E, Schlesinger LS, Agrewala JN. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of . Autophagy. PMID 31462144 DOI: 10.1080/15548627.2019.1658436  0.304
2019 Leopold Wager CM, Arnett E, Schlesinger LS. Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know. Tuberculosis (Edinburgh, Scotland). PMID 31060958 DOI: 10.1016/j.tube.2019.04.016  0.382
2019 Moliva JI, Duncan MA, Olmo-Fontánez A, Akhter A, Arnett E, Scordo JM, Ault R, Sasindran SJ, Azad AK, Montoya MJ, Reinhold-Larsson N, Rajaram MVS, Merrit RE, Lafuse WP, Zhang L, ... ... Schlesinger LS, et al. The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection. The Journal of Infectious Diseases. PMID 30923818 DOI: 10.1093/Infdis/Jiz138  0.346
2018 Guirado E, Rajaram MV, Chawla A, Daigle J, La Perle KM, Arnett E, Turner J, Schlesinger LS. Deletion of PPARγ in lung macrophages provides an immunoprotective response against M. tuberculosis infection in mice. Tuberculosis (Edinburgh, Scotland). 111: 170-177. PMID 30029904 DOI: 10.1016/J.Tube.2018.06.012  0.382
2018 Arnett E, Weaver AM, Woodyard KC, Montoya MJ, Li M, Hoang KV, Hayhurst A, Azad AK, Schlesinger LS. PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis. Plos Pathogens. 14: e1007100. PMID 29928066 DOI: 10.1371/journal.ppat.1007100  0.386
2018 Papp AC, Azad AK, Pietrzak M, Williams A, Handelman SK, Igo RP, Stein CM, Hartmann K, Schlesinger LS, Sadee W. AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection. Plos One. 13: e0198221. PMID 29847580 DOI: 10.1371/journal.pone.0198221  0.374
2018 Garfoot AL, Goughenour KD, Wüthrich M, Rajaram MVS, Schlesinger LS, Klein BS, Rappleye CA. O-Mannosylation of Proteins Enables Histoplasma Yeast Survival at Mammalian Body Temperatures. Mbio. 9. PMID 29295913 DOI: 10.1128/Mbio.02121-17  0.303
2017 Pyle CJ, Azad AK, Papp AC, Sadee W, Knoell DL, Schlesinger LS. Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis. International Journal of Molecular Sciences. 18. PMID 29120360 DOI: 10.3390/ijms18112375  0.392
2017 Lavalett L, Rodriguez H, Ortega H, Sadee W, Schlesinger LS, Barrera LF. Alveolar macrophages from tuberculosis patients display an altered inflammatory gene expression profile. Tuberculosis (Edinburgh, Scotland). 107: 156-167. PMID 29050765 DOI: 10.1016/j.tube.2017.08.012  0.338
2017 Rajaram MVS, Arnett E, Azad AK, Guirado E, Ni B, Gerberick AD, He LZ, Keler T, Thomas LJ, Lafuse WP, Schlesinger LS. M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1. Cell Reports. 21: 126-140. PMID 28978467 DOI: 10.1016/J.Celrep.2017.09.034  0.336
2017 Wright CC, Hsu FF, Arnett E, Dunaj JL, Davidson PM, Pacheco SA, Harriff MJ, Lewinsohn DM, Schlesinger LS, Purdy GE. The Mycobacterium tuberculosis MmpL11 cell wall lipid transporter is important for biofilm formation, intracellular growth and non-replicating persistence. Infection and Immunity. PMID 28507063 DOI: 10.1128/Iai.00131-17  0.37
2016 Schorey JS, Schlesinger LS. Innate Immune Responses to Tuberculosis. Microbiology Spectrum. 4. PMID 28087945 DOI: 10.1128/Microbiolspec.Tbtb2-0010-2016  0.392
2016 Dodd CE, Pyle CJ, Glowinski R, Rajaram MV, Schlesinger LS. CD36-Mediated Uptake of Surfactant Lipids by Human Macrophages Promotes Intracellular Growth of Mycobacterium tuberculosis. Journal of Immunology (Baltimore, Md. : 1950). 197: 4727-4735. PMID 27913648 DOI: 10.4049/jimmunol.1600856  0.329
2016 Zimmermann N, Thormann V, Hu B, Köhler AB, Imai-Matsushima A, Locht C, Arnett E, Schlesinger LS, Zoller T, Schürmann M, Kaufmann SH, Wardemann H. Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis. Embo Molecular Medicine. PMID 27729388 DOI: 10.15252/emmm.201606330  0.301
2016 Hao W, Schlesinger LS, Friedman A. Modeling Granulomas in Response to Infection in the Lung. Plos One. 11: e0148738. PMID 26986986 DOI: 10.1371/Journal.Pone.0148738  0.338
2015 Landes MB, Rajaram MV, Nguyen H, Schlesinger LS. Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages. Journal of Leukocyte Biology. 97: 1111-9. PMID 25801769 DOI: 10.1189/jlb.3A1114-557R  0.417
2015 Guirado E, Mbawuike U, Keiser TL, Arcos J, Azad AK, Wang SH, Schlesinger LS. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. Mbio. 6: e02537-14. PMID 25691598 DOI: 10.1128/Mbio.02537-14  0.755
2015 Pasula R, Azad AK, Gardner JC, Schlesinger LS, McCormack FX. Keratinocyte growth factor administration attenuates murine pulmonary mycobacterium tuberculosis infection through granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent macrophage activation and phagolysosome fusion. The Journal of Biological Chemistry. 290: 7151-9. PMID 25605711 DOI: 10.1074/jbc.M114.591891  0.347
2015 Behr M, Ellis R, Ernst J, Evans T, Flynn J, Hatherill M, Hoft D, Lalvani A, McShane H, Nardell E, Ordway D, Ramanathan R, Ruhwald M, Schlesinger L, Self S, et al. Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: Conference proceedings. National Institute of Allergy and Infectious Diseases, Rockville, Maryland USA, November 7, 2014. Vaccine. 33: 3056-3064. DOI: 10.1016/J.Vaccine.2015.03.061  0.331
2014 Rajaram MV, Ni B, Dodd CE, Schlesinger LS. Macrophage immunoregulatory pathways in tuberculosis. Seminars in Immunology. 26: 471-85. PMID 25453226 DOI: 10.1016/j.smim.2014.09.010  0.405
2014 Gillette DD, Curry HM, Cremer T, Ravneberg D, Fatehchand K, Shah PA, Wewers MD, Schlesinger LS, Butchar JP, Tridandapani S, Gavrilin MA. Virulent Type A Francisella tularensis actively suppresses cytokine responses in human monocytes. Frontiers in Cellular and Infection Microbiology. 4: 45. PMID 24783062 DOI: 10.3389/Fcimb.2014.00045  0.307
2014 Restrepo BI, Twahirwa M, Rahbar MH, Schlesinger LS. Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. Plos One. 9: e92977. PMID 24671137 DOI: 10.1371/Journal.Pone.0092977  0.31
2014 Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MV, Schlesinger LS, Divangahi M, Reed MB, Behr MA. N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis. The Journal of Infectious Diseases. 209: 1045-54. PMID 24265438 DOI: 10.1093/infdis/jit622  0.381
2013 Guirado E, Schlesinger LS, Kaplan G. Macrophages in tuberculosis: friend or foe. Seminars in Immunopathology. 35: 563-83. PMID 23864058 DOI: 10.1007/s00281-013-0388-2  0.41
2013 Guirado E, Schlesinger LS. Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease. Frontiers in Immunology. 4: 98. PMID 23626591 DOI: 10.3389/fimmu.2013.00098  0.388
2013 Yang L, Sinha T, Carlson TK, Keiser TL, Torrelles JB, Schlesinger LS. Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth. Glycobiology. 23: 926-34. PMID 23576535 DOI: 10.1093/Glycob/Cwt029  0.745
2013 Dai S, Rajaram MV, Curry HM, Leander R, Schlesinger LS. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. Plos Pathogens. 9: e1003114. PMID 23359218 DOI: 10.1371/journal.ppat.1003114  0.313
2012 Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS. Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. American Journal of Physiology. Lung Cellular and Molecular Physiology. 303: L608-16. PMID 22886503 DOI: 10.1152/ajplung.00067.2012  0.325
2011 Rajaram MV, Ni B, Morris JD, Brooks MN, Carlson TK, Bakthavachalu B, Schoenberg DR, Torrelles JB, Schlesinger LS. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proceedings of the National Academy of Sciences of the United States of America. 108: 17408-13. PMID 21969554 DOI: 10.1073/Pnas.1112660108  0.348
2011 Keiser TL, Azad AK, Guirado E, Bonacci R, Schlesinger LS. Comparative transcriptional study of the putative mannose donor biosynthesis genes in virulent Mycobacterium tuberculosis and attenuated Mycobacterium bovis BCG strains. Infection and Immunity. 79: 4668-73. PMID 21896775 DOI: 10.1128/Iai.05635-11  0.753
2011 Torrelles JB, Sieling PA, Arcos J, Knaup R, Bartling C, Rajaram MV, Stenger S, Modlin RL, Schlesinger LS. Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses. The Journal of Biological Chemistry. 286: 35438-46. PMID 21859718 DOI: 10.1074/Jbc.M111.232587  0.308
2011 Arcos J, Sasindran SJ, Fujiwara N, Turner J, Schlesinger LS, Torrelles JB. Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection. Journal of Immunology (Baltimore, Md. : 1950). 187: 372-81. PMID 21602490 DOI: 10.4049/Jimmunol.1100823  0.357
2011 Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, Sable SB. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis (Edinburgh, Scotland). 91: 314-21. PMID 21482189 DOI: 10.1016/J.Tube.2011.03.003  0.344
2011 Brooks MN, Rajaram MV, Azad AK, Amer AO, Valdivia-Arenas MA, Park JH, Núñez G, Schlesinger LS. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cellular Microbiology. 13: 402-18. PMID 21040358 DOI: 10.1111/j.1462-5822.2010.01544.x  0.413
2010 Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 929-42. PMID 20554962 DOI: 10.4049/jimmunol.1000866  0.363
2010 Mohapatra NP, Soni S, Rajaram MV, Dang PM, Reilly TJ, El-Benna J, Clay CD, Schlesinger LS, Gunn JS. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. Journal of Immunology (Baltimore, Md. : 1950). 184: 5141-50. PMID 20348422 DOI: 10.4049/Jimmunol.0903413  0.718
2010 Torrelles JB, Schlesinger LS. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinburgh, Scotland). 90: 84-93. PMID 20199890 DOI: 10.1016/j.tube.2010.02.003  0.433
2010 Clay CD, Gunn JS, Schlesinger LS. Antibody-independent classical complement pathway activation by wildtype and LPS O-antigen mutant Francisella tularensis strains Molecular Immunology. 47: 2245-2245. DOI: 10.1016/J.Molimm.2010.05.146  0.7
2009 Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, Elton TS, Gunn JS, Amer A, Kanneganti TD, Schlesinger LS, Butchar JP, Tridandapani S. MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. Plos One. 4: e8508. PMID 20041145 DOI: 10.1371/Journal.Pone.0008508  0.706
2009 Day J, Friedman A, Schlesinger LS. Modeling the immune rheostat of macrophages in the lung in response to infection. Proceedings of the National Academy of Sciences of the United States of America. 106: 11246-51. PMID 19549875 DOI: 10.1016/J.Jcrc.2009.06.020  0.419
2009 Premanandan C, Storozuk CA, Clay CD, Lairmore MD, Schlesinger LS, Phipps AJ. Complement protein C3 binding to Bacillus anthracis spores enhances phagocytosis by human macrophages. Microbial Pathogenesis. 46: 306-14. PMID 19328844 DOI: 10.1016/J.Micpath.2009.03.004  0.716
2009 Torrelles JB, DesJardin LE, MacNeil J, Kaufman TM, Kutzbach B, Knaup R, McCarthy TR, Gurcha SS, Besra GS, Clegg S, Schlesinger LS. Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology. 19: 743-55. PMID 19318518 DOI: 10.1093/Glycob/Cwp042  0.396
2008 Clay CD, Soni S, Gunn JS, Schlesinger LS. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. Journal of Immunology (Baltimore, Md. : 1950). 181: 5568-78. PMID 18832715  0.726
2008 Torrelles JB, Knaup R, Kolareth A, Slepushkina T, Kaufman TM, Kang P, Hill PJ, Brennan PJ, Chatterjee D, Belisle JT, Musser JM, Schlesinger LS. Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. The Journal of Biological Chemistry. 283: 31417-28. PMID 18784076 DOI: 10.1074/Jbc.M806350200  0.319
2008 Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, Marsh CB, Schlesinger LS, Tridandapani S. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. Plos One. 3: e2924. PMID 18698339 DOI: 10.1371/Journal.Pone.0002924  0.745
2008 Van Zandt KE, Sow FB, Florence WC, Zwilling BS, Satoskar AR, Schlesinger LS, Lafuse WP. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. Journal of Leukocyte Biology. 84: 689-700. PMID 18586980 DOI: 10.1189/Jlb.1107781  0.366
2008 Parsa KV, Butchar JP, Rajaram MV, Cremer TJ, Gunn JS, Schlesinger LS, Tridandapani S. Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response. Molecular Immunology. 45: 3428-37. PMID 18514317 DOI: 10.1016/J.Molimm.2008.04.006  0.336
2008 Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS. Role of C-type lectins in mycobacterial infections. Current Drug Targets. 9: 102-12. PMID 18288961 DOI: 10.2174/138945008783502467  0.349
2007 Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. Journal of Leukocyte Biology. 82: 934-45. PMID 17609338 DOI: 10.1189/Jlb.0407216  0.33
2007 Butchar JP, Rajaram MV, Ganesan LP, Parsa KV, Clay CD, Schlesinger LS, Tridandapani S. Francisella tularensis induces IL-23 production in human monocytes. Journal of Immunology (Baltimore, Md. : 1950). 178: 4445-54. PMID 17372002 DOI: 10.4049/Jimmunol.178.7.4445  0.721
2007 Mohapatra NP, Balagopal A, Soni S, Schlesinger LS, Gunn JS. AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infection and Immunity. 75: 390-6. PMID 17060465 DOI: 10.1128/IAI.01226-06  0.324
2006 Torrelles JB, Azad AK, Schlesinger LS. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. Journal of Immunology (Baltimore, Md. : 1950). 177: 1805-16. PMID 16849491  0.325
2006 Parsa KV, Ganesan LP, Rajaram MV, Gavrilin MA, Balagopal A, Mohapatra NP, Wewers MD, Schlesinger LS, Gunn JS, Tridandapani S. Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. Plos Pathogens. 2: e71. PMID 16848641 DOI: 10.1371/Journal.Ppat.0020071  0.322
2006 Hall-Stoodley L, Watts G, Crowther JE, Balagopal A, Torrelles JB, Robison-Cox J, Bargatze RF, Harmsen AG, Crouch EC, Schlesinger LS. Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions. Infection and Immunity. 74: 3587-96. PMID 16714591 DOI: 10.1128/Iai.01644-05  0.379
2005 McCarthy TR, Torrelles JB, MacFarlane AS, Katawczik M, Kutzbach B, Desjardin LE, Clegg S, Goldberg JB, Schlesinger LS. Overexpression of Mycobacterium tuberculosis manB, a phosphomannomutase that increases phosphatidylinositol mannoside biosynthesis in Mycobacterium smegmatis and mycobacterial association with human macrophages. Molecular Microbiology. 58: 774-90. PMID 16238626 DOI: 10.1111/J.1365-2958.2005.04862.X  0.403
2004 Ferguson JS, Weis JJ, Martin JL, Schlesinger LS. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infection and Immunity. 72: 2564-73. PMID 15102764  0.335
2003 Brown RM, Cruz O, Brennan M, Gennaro ML, Schlesinger L, Skeiky YA, Hoft DF. Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination. The Journal of Infectious Diseases. 187: 513-7. PMID 12552438 DOI: 10.1086/368096  0.338
2002 DesJardin LE, Kaufman TM, Potts B, Kutzbach B, Yi H, Schlesinger LS. Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor. Microbiology (Reading, England). 148: 3161-71. PMID 12368450 DOI: 10.1099/00221287-148-10-3161  0.37
2002 Ferguson JS, Voelker DR, Ufnar JA, Dawson AJ, Schlesinger LS. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. Journal of Immunology (Baltimore, Md. : 1950). 168: 1309-14. PMID 11801670  0.314
1998 Schlesinger LS. Mycobacterium tuberculosis and the complement system. Trends in Microbiology. 6: 47-9; discussion 49-. PMID 9507637 DOI: 10.1016/S0966-842X(97)01203-1  0.343
1996 Kusner DJ, Hall CF, Schlesinger LS. Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages Journal of Experimental Medicine. 184: 585-595. PMID 8760812 DOI: 10.1084/Jem.184.2.585  0.341
Show low-probability matches.